Mitotic catastrophe in malignant epithelial tumors: The pathologist's viewpoint

Ultrastructural Pathology

Volumn 35, Issue 2, 2011, Pages 66-71

  Caruso, Rosario ^a,b   Fedele, Francesco ^a   Lucianò, Roberta ^a   Branca, Giovanni ^a   Parisi, Claudia ^a   Paparo, Domenica ^a   Parisi, Antonino ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Mitotic catastrophe

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TP53 PROTEIN, HUMAN;

AGED; ARTICLE; CARCINOMA; CASE REPORT; CELL DEATH; CELL NUCLEUS; CENTROSOME; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MITOSIS; MITOSIS INDEX; NOMENCLATURE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; ULTRASTRUCTURE;

AGED; CARCINOMA; CELL DEATH; CELL NUCLEUS; CENTROSOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MITOSIS; MITOTIC INDEX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TERMINOLOGY AS TOPIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79851501162     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2010.543753     Document Type: Article

References (44)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Kerr, JF, Gobe GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol. 1995;46:1-27.
3. Kroemer G, El-Deiry WS, Golstein P, et al.; Nomenclature Committee on Cell Death. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death Cell Death Differ. 2005;12 (Suppl 2):1463-1467.
4. Galluzzi L, Aaronson SA, Abrams J, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 2009;16:1093-1107.
5. Sengupta S, Lohse CM, Leibovich BC, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 2005;104:511-520. (Pubitemid 41022807)
6. Tollefson MK, Thompson RH, Sheinin Y, et al. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer. 2007;110:783-790. (Pubitemid 47257655)
7. Katz MD, Serrano MF, Grubb RL 3rd, et al. Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010;183:909-914.
8. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869-10874. (Pubitemid 32878711)
9. Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19:264-271. (Pubitemid 43117611)
10. Jimenez RE, Wallis T, Visscher DW. Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol. 2001;25:331-337. (Pubitemid 32174202)
11. Maiorano E, Regan MM, Viale G, et al. Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy. Breast Cancer Res Treat. 2010;121:211-218.
12. Fulford LG, Easton DF, Reis-Filho JS, et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology. 2006;49:22-34. (Pubitemid 43972917)
13. Swinson DE, Jones JL, Richardson D, Cox G, Edwards JG, O'Byrne KJ. Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer. 2002;37:235-240. (Pubitemid 35291153)
14. Hiltzik D, Carlson DL, Tuttle RM, et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 2006;106:1286-1295. (Pubitemid 43363905)
15. Caruso RA, Fedele F, Finocchiaro G, et al. Microvascular changes in human gastric carcinomas with coagulative necrosis: an ultrastructural study. Ultrastruct Pathol. 2008;32:184-188.
16. Pollheimer MJ, Kornprat P, Lindtner RA, et al. Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol. 2010 Sep 22. [Epub ahead of print]
17. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000;97:14376-14381. (Pubitemid 32016583)
18. Erenpreisa Je, Ivanov A, Dekena G, et al. Arrest in metaphase and anatomy of mitotic catastrophe mild heat shock in two human osteosarcoma cell lines: Cell Biol Int. 2000; 24:61-71
19. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 2004; 23: 2825-2837. (Pubitemid 38638845)
20. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ. 2008; 15: 1153-1162. (Pubitemid 351850968)
21. Ianzini F, Cherubini R, Mackey MA. Mitotic catastrophe induced by exposure of V79 Chinese hamster cells to low energy protons. Int J Radiat Biol. 1999; 75:717-723. (Pubitemid 29298103)
22. Swanson PE, Carroll SB, Zhang XF, Mackey MA. Spontaneous premature chromosome condensation micronucleus formation, and non-apoptotic cell death in heated HeLa S3 cells. Am J Pathol. 1995;146: 963-971
23. Roninson IB, Broude EV, Chang BD. If not apoptosis, then what?-treatment-induced senescence and mitotic catastrophe in tumor cell. Drug Resist Update. 2001;4: 303-313. (Pubitemid 34456384)
24. Al-Nafussi AI, Hughes DE. Histological Diagnosis of Tumours by Pattern Analysis. London: Arnold; 1997.
25. Kroemer G, Galluzzi L, Vandenabeele P, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009;16:3-11.
26. Baehrecke EH. Growth control: p53 the guardian angel of compensatory proliferation. Curr Biol. 2006;16:R840-R842. (Pubitemid 44486769)
27. Hashimoto T, Tokuchi Y, Hayashi M, et al. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Cancer Res. 1999; 59: 5572-5577. (Pubitemid 29526476)
28. Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11:174-183.
29. Bornens M. Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol. 2002;14:25-34. (Pubitemid 34131653)
30. Pihan GS, Purohit A, Wallace J, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998; 58:3974-3985. (Pubitemid 28405657)
31. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W. Centrosome amplification drives chromosomal instability in breast tumor development. Cell Biol. 2002; 99:1978-1983. (Pubitemid 34169000)
32. Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in preinvasive carcinomas. Cancer Res. 2003;63:1398-404. (Pubitemid 36348723)
33. Lingle WL, Salisbury JL. Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am J Pathol. 1999;155:1941-1951.
34. Liang YX, Zhang W, Li DD, et al. Mitotic cell death in BEL- 7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication. World J Gastroenterol. 2004;10:2632-2636. (Pubitemid 39214492)
35. Malorni W, Fiorentini C. Is the Rac GTPase-activating toxin CNF1 a smart hijacker of host cell fate? FASEB J. 2006;20:606-609. (Pubitemid 44933304)
36. Gisselsson D, Bjork J, Hoglund M, et al. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol. 2001;158:199-206. (Pubitemid 32096485)
37. Gisselsson D. Classification of chromosome segregation errors in cancer. Chromosoma. 2008;117:511-519.
38. Fenech M. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res. 2006; 600: 58-66.
39. Shimizu N, Itoh N, Utiyama H, Wahl GM. Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S-phase. J Cell Biol. 1998; 140:1307-1320. (Pubitemid 28152981)
40. Utani K-I, Kohno Y, Okamoto A, Shimizu N. Emergence of micronuclei and their effects on the fate of cells under replication stress.PLos ONE. 2010;5(4: e10089
41. Nguyen CV, Falcón-Escobedo R, Hunt KK, et al. Pleomorphic ductal carcinoma of the breast: predictors of decreased overall survival. Am J Surg Pathol. 2010; 34:486-493.
42. Zhao J, Lang R, Guo X, et al. Clinicopathologic characteristics of pleomorphic carcinoma of the breast. Virchows Arch. 2010; 456:31-37.
43. Caruso RA, Fedele F, Crisafulli C, et al. Abnormal nuclear structures (micronuclei, nuclear blebs, strings, and pockets in a case of anaplastic giant cell carcinoma of the thyroid: an immunohistochemical and ultrastructural study.Ultrastruct Pathol. 2010 Oct 7. [Epub ahead of print]
44. Caruso RA, Fedele F, Consolo P, Luigiano C, Venuti A, Cavallari V. Abnormal nuclear structures (micronuclei, nucleoplasmic bridges, and nuclear buds) in a pleomorphic giant cell carcinoma of the stomach. Ultrastruct Pathol. 2008;32:11-15. (Pubitemid 351323401)